GR81500B - - Google Patents

Info

Publication number
GR81500B
GR81500B GR75245A GR840175245A GR81500B GR 81500 B GR81500 B GR 81500B GR 75245 A GR75245 A GR 75245A GR 840175245 A GR840175245 A GR 840175245A GR 81500 B GR81500 B GR 81500B
Authority
GR
Greece
Application number
GR75245A
Inventor
Robert D Sitrin
Kenneth M Snader
Gail Folena Wasserman
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of GR81500B publication Critical patent/GR81500B/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9446—Antibacterials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
GR75245A 1983-07-13 1984-07-09 GR81500B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/513,511 US4667024A (en) 1983-07-13 1983-07-13 Process for the preparation of purified vancomycin class antibiotics

Publications (1)

Publication Number Publication Date
GR81500B true GR81500B (el) 1984-12-11

Family

ID=24043588

Family Applications (1)

Application Number Title Priority Date Filing Date
GR75245A GR81500B (el) 1983-07-13 1984-07-09

Country Status (10)

Country Link
US (1) US4667024A (el)
EP (1) EP0132117A3 (el)
JP (1) JPS6038389A (el)
AU (1) AU3040984A (el)
CA (1) CA1238315A (el)
DK (1) DK339084A (el)
ES (1) ES534247A0 (el)
GR (1) GR81500B (el)
PT (1) PT78879B (el)
ZA (1) ZA845335B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4548974A (en) * 1983-07-13 1985-10-22 Smithkline Beckman Corporation Antibiotics produced by Kibdelosporangium aridum shearer
ATE42317T1 (de) * 1983-07-29 1989-05-15 Henning Berlin Gmbh Voraktivierte kunststoffoberflaechen zur immobilisierung von organisch-chemischen und biologischen materialien, verfahren zur herstellung und verwendung derselben.
GR81191B (en) * 1983-12-12 1985-04-08 Lilly Co Eli Vancomycin purification improvement and product
GB8427436D0 (en) * 1984-10-30 1984-12-05 Lepetit Spa Receptor assay
GB8608798D0 (en) * 1986-04-11 1986-05-14 Lepetit Spa Recovery of glycopeptide antibiotics from aqueous solutions
ZA877192B (en) * 1986-10-01 1988-10-26 Smithkline Beckman Corp Affinity purification process for glycopeptide antibiotics
JP2577133B2 (ja) 1989-11-27 1997-01-29 スティフティング フォール ド テフニスヘ ウェッテンスハッペン 船舶のプロペラ
US5574135A (en) * 1990-07-10 1996-11-12 Abbott Laboratories Process for making vancomycin
US5149784A (en) * 1990-07-10 1992-09-22 Abbott Laboratories Process for making vancomycin
US5258495A (en) * 1990-07-10 1993-11-02 Abbott Laboratories Process for making vancomycin HC1
US5372719A (en) * 1992-03-30 1994-12-13 Perseptive Biosystems, Inc. Molecular imaging
DE69319428T2 (de) * 1992-04-20 1999-02-04 Abbott Laboratories, Abbott Park, Ill. Verfahren zur herstellung von vancomycin
US5626757A (en) * 1994-02-22 1997-05-06 Advanced Separation Technologies Inc. Macrocyclic antibiotics as separation agents
SI9500040B (sl) * 1995-02-07 2002-02-28 Lek, Kromatografsko čiščenje Vankomicin hidroklorida z uporabo preparativne HPLC
US5773089A (en) * 1996-12-18 1998-06-30 E. I. Du Pont De Nemours And Company Process for treating aramid surfaces to be plated
TWI233932B (en) * 2001-08-24 2005-06-11 Theravance Inc Process for purifying glycopeptide phosphonate derivatives
US20050106703A1 (en) * 2003-11-05 2005-05-19 Kyowa Hakko Kogyo Co., Ltd. Microorganisms producing dipeptides and process for producing dipeptides using the microorganisms
EP1798237A1 (en) * 2005-12-16 2007-06-20 Pharmatex Italia Srl Process for the purification of macrolide antibiotics
ITLO20110001A1 (it) 2011-05-03 2012-11-04 Fisiopharma Srl Flaconi di vancomicina cloroidrata con stabilità migliorata

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985690A (en) * 1971-02-11 1976-10-12 Peter Duncan Goodearl Dean Enzyme separation
US3952095A (en) * 1972-06-02 1976-04-20 Eli Lilly And Company Novel antibiotic and a process for the production thereof
US3928571A (en) * 1972-12-15 1975-12-23 Lilly Co Eli Ruminant feed utilization improvement
CS175047B1 (el) * 1974-04-25 1977-04-29
US4083964A (en) * 1976-05-24 1978-04-11 Eli Lilly And Company Antibiotic A-35512 for increasing feed utilization efficiency in an animal
US4169141A (en) * 1978-01-30 1979-09-25 Shering Corporation 1-Peptidyl derivatives of di-O-aminoglycosyl-1,3-diaminocyclitol antibacterial agents
US4378348A (en) * 1979-12-28 1983-03-29 Otsuka Pharmaceutical Co., Ltd. OA-7653 Substance
US4491660A (en) * 1980-01-10 1985-01-01 Abbott Laboratories Matrix polymers for binding endotoxins
US4461723A (en) * 1980-12-18 1984-07-24 Eli Lilly And Company Antibiotic A-4696 factor G
US4416994A (en) * 1981-10-19 1983-11-22 Eli Lilly And Company Plasmid pEL7 and related cloning vectors for use in streptomyces and related organisms
US4440753A (en) * 1982-03-15 1984-04-03 Eli Lilly And Company Purification of glycopeptide antibiotics using non-functional resins
US4468462A (en) * 1982-12-22 1984-08-28 Eli Lilly And Company Vectors for cloning in streptomyces
GB8311136D0 (en) * 1983-04-25 1983-06-02 Lepetit Spa Immobilised oligopeptides

Also Published As

Publication number Publication date
ES8505696A1 (es) 1985-06-01
AU3040984A (en) 1985-01-17
CA1238315A (en) 1988-06-21
PT78879A (en) 1984-08-01
EP0132117A3 (en) 1987-04-15
JPS6038389A (ja) 1985-02-27
PT78879B (en) 1986-07-22
US4667024A (en) 1987-05-19
DK339084D0 (da) 1984-07-10
ES534247A0 (es) 1985-06-01
DK339084A (da) 1985-01-14
EP0132117A2 (en) 1985-01-23
ZA845335B (en) 1985-09-25

Similar Documents

Publication Publication Date Title
BR8407173A (el)
DE3470995T (el)
GR81500B (el)
DE8301751U1 (el)
GR72018B (el)
GR71496B (el)
DK448584D0 (el)
GR72571B (el)
GR72564B (el)
BR6301293U (el)
GR72447B (el)
GR72373B (el)
GR72605B (el)
BG45249A1 (el)
BG44974A1 (el)
BG45379A1 (el)
BG45371A1 (el)
BG45370A1 (el)
BG45369A1 (el)
BG45363A1 (el)
BG44648A1 (el)
BG45346A1 (el)
BG45339A1 (el)
BG45255A1 (el)
CA1250532C (el)